Bill > SF2071

This bill prohibits health plans that provide diabetes treatment coverage from using step therapy protocols (a practice where patients must try less expensive or alternative medications before accessing their prescribed drug) for insulin medications. The bill defines diabetes as the three types recognized by the Centers for Disease Control and Prevention and clarifies that "prescription insulin drug" has a specific meaning as outlined in another section of Minnesota law. Under this legislation, health insurers cannot require patients to try alternative insulin drugs before accessing their prescribed medication, which aims to improve patient care by removing potential barriers to accessing the most appropriate insulin treatment. The bill will take effect on January 1, 2027, and will apply to all health plans offered, issued, or renewed on or after that date. By preventing step therapy requirements for insulin drugs, the bill seeks to ensure that patients with diabetes can more quickly and directly access the specific insulin medications recommended by their healthcare providers, potentially reducing treatment delays and improving patient outcomes.

Business and Industry

https://www.revisor.mn.gov/bills/bill.php?b=Senate&f=SF2071&ssn=0&y=2025